Cell type-specific expression of the putative SARS-CoV-2 receptor ACE2 in human hearts
Top Cited Papers
Open Access
- 15 April 2020
- journal article
- editorial
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 41 (19), 1804-1806
- https://doi.org/10.1093/eurheartj/ehaa311
Abstract
See page 1807 for the editorial comment on this article (doi: 10.1093/eurheartj/ehaa410)Funding Information
- DFG (Exc2026)
- Rolf M. Schwiete foundation
This publication has 12 references indexed in Scilit:
- Influence of glenohumeral joint muscle insertion on moment arms using a finite element modelComputer Methods in Biomechanics and Biomedical Engineering, 2020
- Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington StateJAMA, 2020
- Faculty Opinions recommendation of Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis.Published by H1 Connect ,2020
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease InhibitorCell, 2020
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, ChinaThe Lancet, 2020
- Role of the ACE2/Angiotensin 1–7 Axis of the Renin–Angiotensin System in Heart FailureCirculation Research, 2016
- Renin–angiotensin system in human coronavirus pathogenesisFuture Virology, 2010
- A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injuryNature Medicine, 2005
- Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesisThe Journal of Pathology, 2004
- ACEH/ACE2 is a novel mammalian metallocarboxypeptidase and a homologue of angiotensin-converting enzyme insensitive to ACE inhibitorsCanadian Journal of Physiology and Pharmacology, 2002